Fulcrum Therapeutics, Inc. FULC
3.74
(0.05)
(1.32%)
as of 25 Sep
- Market cap
- $288.8M
- P/E
- 0.0×
Follow FULC
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
30.96 | 33.79 | 27.00 | 17.25 | |
Current Ratio |
31.35 | 34.33 | 27.40 | 17.70 | |
Net Debt/EBITDA |
10.96 | 15.26 | 15.77 | 9.33 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.61 | 0.99 | 0.83 | 0.72 | |
Capex/Depreciation |
1.58 | (0.02) | (0.46) | (0.26) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.21) | (0.25) | (0.27) | (0.23) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.21) | (0.25) | (0.27) | (0.23) | |
Cash per Share |
4.18 | 4.37 | 5.56 | 3.21 | |
Shareholders Equity per Share |
4.07 | 4.37 | 5.51 | 3.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.07 | 4.37 | 5.51 | 3.17 | |
Free Cash Flow |
(15.70) | (18.76) | (16.96) | (14.28) | |
Working Capital |
312.55 | 328.81 | 344.43 | 194.23 | |
Capital Expenditures |
0.34 | (0.01) | (0.16) | (0.09) | |
Net Current Asset Value |
309.60 | 325.20 | 340.20 | 189.37 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.59 | 1.98 | 1.38 | 3.45 | |
Average Assets |
276.40 | 294.71 | 313.50 | 246.93 | |
Average Common Equity |
262.54 | 280.89 | 296.02 | 227.83 |
Columns are period end dates